These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31541799)

  • 1. The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells.
    Affinito A; Quintavalle C; Esposito CL; Roscigno G; Vilardo C; Nuzzo S; Ricci-Vitiani L; De Luca G; Pallini R; Kichkailo AS; Lapin IN; de Franciscis V; Condorelli G
    Mol Ther Nucleic Acids; 2019 Dec; 18():99-109. PubMed ID: 31541799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells.
    Affinito A; Quintavalle C; Esposito CL; Roscigno G; Giordano C; Nuzzo S; Ricci-Vitiani L; Scognamiglio I; Minic Z; Pallini R; Berezovski MV; de Francisis V; Condorelli G
    Mol Ther Nucleic Acids; 2020 Jun; 20():176-185. PubMed ID: 32169805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of RNA and DNA Aptamers in Glioblastoma Diagnosis and Therapy: A Systematic Review of the Literature.
    Nuzzo S; Brancato V; Affinito A; Salvatore M; Cavaliere C; Condorelli G
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32764266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Glioblastoma Stem Cells: A Review on Biomarkers, Signal Pathways and Targeted Therapy.
    Tang X; Zuo C; Fang P; Liu G; Qiu Y; Huang Y; Tang R
    Front Oncol; 2021; 11():701291. PubMed ID: 34307170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate.
    Chen Q; Wu J; Ye Q; Ma F; Zhu Q; Wu Y; Shan C; Xie X; Li D; Zhan X; Li C; Li XF; Qin X; Zhao T; Wu H; Shi PY; Man J; Qin CF
    mBio; 2018 Sep; 9(5):. PubMed ID: 30228241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Targeting of Glioblastoma Stem-Like Cells by Neutralizing RNA-Bio-Drugs for STAT3.
    Esposito CL; Nuzzo S; Ibba ML; Ricci-Vitiani L; Pallini R; Condorelli G; Catuogno S; de Franciscis V
    Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32486489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different states of stemness of glioblastoma stem cells sustain glioblastoma subtypes indicating novel clinical biomarkers and high-efficacy customized therapies.
    Visioli A; Trivieri N; Mencarelli G; Giani F; Copetti M; Palumbo O; Pracella R; Cariglia MG; Barile C; Mischitelli L; Soriano AA; Palumbo P; Legnani F; DiMeco F; Gorgoglione L; Pesole G; Vescovi AL; Binda E
    J Exp Clin Cancer Res; 2023 Sep; 42(1):244. PubMed ID: 37735434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multistep In Silico Approach Identifies Potential Glioblastoma Drug Candidates via Inclusive Molecular Targeting of Glioblastoma Stem Cells.
    Dogra N; Singh P; Kumar A
    Mol Neurobiol; 2024 Apr; ():. PubMed ID: 38619743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
    Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
    Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of miR-181a suppresses the formation of glioblastoma stem cells by targeting the Notch2 oncogene and correlates with good prognosis in patients with glioblastoma multiforme.
    Huang SX; Zhao ZY; Weng GH; He XY; Wu CJ; Fu CY; Sui ZY; Ma YS; Liu T
    Biochem Biophys Res Commun; 2017 May; 486(4):1129-1136. PubMed ID: 28389242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective lentiviral gene delivery to CD133-expressing human glioblastoma stem cells.
    Bayin NS; Modrek AS; Dietrich A; Lebowitz J; Abel T; Song HR; Schober M; Zagzag D; Buchholz CJ; Chao MV; Placantonakis DG
    PLoS One; 2014; 9(12):e116114. PubMed ID: 25541984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted delivery of tumor suppressor microRNA-1 by transferrin-conjugated lipopolyplex nanoparticles to patient-derived glioblastoma stem cells.
    Wang X; Huang X; Yang Z; Gallego-Perez D; Ma J; Zhao X; Xie J; Nakano I; Lee LJ
    Curr Pharm Biotechnol; 2014; 15(9):839-46. PubMed ID: 25374033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aptamer-Based In Vivo Therapeutic Targeting of Glioblastoma.
    Cesarini V; Scopa C; Silvestris DA; Scafidi A; Petrera V; Del Baldo G; Gallo A
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32957732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pterostilbene suppressed irradiation-resistant glioma stem cells by modulating GRP78/miR-205 axis.
    Huynh TT; Lin CM; Lee WH; Wu AT; Lin YK; Lin YF; Yeh CT; Wang LS
    J Nutr Biochem; 2015 May; 26(5):466-75. PubMed ID: 25736407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Hypoxia and Cancer Stem Cells in Development of Glioblastoma.
    Shi T; Zhu J; Zhang X; Mao X
    Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stemness Marker Detection in the Periphery of Glioblastoma and Ability of Glioblastoma to Generate Glioma Stem Cells: Clinical Correlations.
    Raysi Dehcordi S; Ricci A; Di Vitantonio H; De Paulis D; Luzzi S; Palumbo P; Cinque B; Tempesta D; Coletti G; Cipolloni G; Cifone MG; Galzio R
    World Neurosurg; 2017 Sep; 105():895-905. PubMed ID: 28559081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
    Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
    PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging targets for glioblastoma stem cell therapy.
    Safa AR; Saadatzadeh MR; Cohen-Gadol AA; Pollok KE; Bijangi-Vishehsaraei K
    J Biomed Res; 2016 Jan; 30(1):19-31. PubMed ID: 26616589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Glioblastoma Stem Cells to Overcome Chemoresistance: An Overview of Current Therapeutic Strategies.
    Kang H; Lee H; Kim D; Kim B; Kang J; Kim HY; Youn H; Youn B
    Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.